New flavan trimer from Daemonorops draco as osteoclastogenesis inhibitor

Fitoterapia. 2024 Jan:172:105757. doi: 10.1016/j.fitote.2023.105757. Epub 2023 Nov 24.

Abstract

Dragon's blood is a red resin obtained from different plants and is considered highly efficacious and used in medicine owing its wound healing function. Two new compounds (7 and 8) were isolated from the dragon's blood of Daemonorops draco fruits, along with eight known compounds (1-6, 9, and 10). Their structures, including their absolute configurations, were elucidated by nuclear magnetic resonance (NMR), matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and electronic circular dichroism (ECD) analysis. According to the spectroscopic data, 8 was determined to be a quinone methide derivative of flavan and 7 was deduced to be a flavan trimer. All compounds were evaluated for their anti-osteoclastogenesis activity, compound 1 and 7 exhibited anti-osteoclastogenesis activity with IC50 values of 31.3 and 36.8 μM, respectively.

Keywords: Daemonorops draco; Dragon's blood; Flavonoid; Osteoclast; Osteoporosis.

MeSH terms

  • Calamus*
  • Magnetic Resonance Spectroscopy
  • Molecular Structure
  • Osteogenesis*
  • Plant Extracts* / chemistry
  • Plants / chemistry

Substances

  • Plant Extracts

Supplementary concepts

  • Calamus draco